Distinguishing concussion from normal aging symptoms has long frustrated emergency physicians treating older patients. When seniors arrive at trauma centers after falls or accidents, determining whether cognitive changes stem from brain injury or age-related decline often relies on subjective assessments that can miss subtle but significant trauma.
This Australian study evaluated four blood-based biomarkers in 60+ adults within 72 hours of suspected head injury, comparing them against community controls. The researchers measured glial fibrillary acidic protein (GFAP), ubiquitin C-terminal hydrolase-L1 (UCH-L1), brain-derived tau (BD-tau), and neurofilament light (NfL) to determine which proteins best distinguished confirmed mild traumatic brain injury cases from uninjured individuals using standardized diagnostic criteria.
The findings represent a critical advancement in geriatric emergency medicine, where objective biomarkers could reduce diagnostic uncertainty that currently leads to both missed injuries and unnecessary interventions. Blood-based testing offers particular advantages over imaging in older adults, who may have pre-existing brain changes that complicate CT interpretation. However, establishing age-specific thresholds remains crucial since baseline protein levels naturally vary with aging processes. The research addresses a significant gap in concussion literature, which has historically focused on younger populations despite older adults comprising a growing share of head injury cases. While promising for clinical implementation, the cross-sectional design limits understanding of how these biomarkers perform across recovery timelines, and larger validation studies across diverse older populations will be essential before widespread adoption in emergency departments.